Current Trends of Lassa fever amidst COVID-19 Pandemic in Nigeria

Authors

  • Jeremiah Oluwamayowa Omojuyigbe Obafemi Awolowo University, Ile-Ife, Nigeria
  • Habeebullah Jayeola Oladipo University of Ilorin, Ilorin, Nigeria
  • Moriam Adesola Adegbite University of Ilorin, Ilorin, Nigeria
  • Yusuf Babatunde University of Ilorin, Ilorin, Nigeria
  • Taiwo Oluwaseun Sokunbi Obafemi Awolowo University, Ile-Ife, Nigeria
  • Oluwakorede Adedeji University of Ilorin, Ilorin, Nigeria
  • Ibrahim Abdulmumin University of Ilorin, Ilorin, Nigeria

DOI:

https://doi.org/10.31646/gbio.179

Keywords:

COVID-19, Lassa fever, Trends, LASV vaccine, epidemic, infectious disease

Abstract

Lassa fever is a disease endemic in West Africa caused by the Lassa virus (LASV). The emergence of the COVID-19 pandemic has put an extra burden on Nigeria in the fight against infectious disease outbreaks. Lassa fever cases peak seasonally in the first three months of the year. Despite the reduction in the epidemiological trends in 2021, the current trends of the Lassa fever cases in Nigeria in 2022 indicate that the virus is still being actively transmitted in the country with some large states regarded as high burden areas. There are requirements to increase in vaccine uptake for COVID-19,  to strengthen the testing capacities for LASV, and develop licensed LASV vaccine, in order to eradicate these viral diseases of concern. This study aims to identify the current trends of Lassa fever in Nigeria, measures and challenges and suggest strategies for curtailing the spread.

Downloads

Published

2023-02-24

How to Cite

Omojuyigbe, J. O., Oladipo, H. J., Adegbite, M. A., Babatunde, Y., Sokunbi, T. O., Adedeji, O., & Abdulmumin, I. (2023). Current Trends of Lassa fever amidst COVID-19 Pandemic in Nigeria. Global Biosecurity, 5(1). https://doi.org/10.31646/gbio.179

Issue

Vol. 5 (2023)

Section

Editorials and Commentaries

License

Copyright (c) 2023 The Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:
  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Received 2022-09-28
Accepted 2023-02-05
Published 2023-02-24